Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MED TECH who wrote (2)	3/31/1997 3:56:00 AM
From: Cuong Huy Nguyen	of 178

Med Tech, I agree that the stock is probably better as a long term investment. I can't seem to find that press release that said they were coming up for review again this September. Was I mistaken in thinking that they would? I'll keep looking for it. But assuming they are going to get reviewed this Fall, do you think they'll get approved the second time around? Also, how long does it take from the time a company is reviewed by a panel like the Hematology and Pathology Devices Panel, and the time actual approval is given from the FDA? Does the FDA always approve something that has been recommended for approval by a panel? thanks, cuong p.s. -- are you worried about the market's slide on thursday continuing tomorrow? I'm getting that nauseous feeling again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next